Related references
Note: Only part of the references are listed.Bioenergetic deficits in Huntington's disease iPSC-derived neural cells and rescue with glycolytic metabolites
Amanda J. Kedaigle et al.
HUMAN MOLECULAR GENETICS (2020)
Metabolic Reprogramming in Astrocytes Distinguishes Region-Specific Neuronal Susceptibility in Huntington Mice
Aris A. Polyzos et al.
CELL METABOLISM (2019)
Striatal neurons directly converted from Huntington's disease patient fibroblasts recapitulate age-associated disease phenotypes
Matheus B. Victor et al.
NATURE NEUROSCIENCE (2018)
XJB-5-131-mediated improvement in physiology and behaviour of the R6/2 mouse model of Huntington's disease is age-and sex-dependent
Aris A. Polyzos et al.
PLOS ONE (2018)
Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases
Niamh M. C. Connolly et al.
CELL DEATH AND DIFFERENTIATION (2018)
Oxidative metabolism and Ca2+ handling in striatal mitochondria from YAC1.28 mice, a model of Huntington's disease
James Hamilton et al.
NEUROCHEMISTRY INTERNATIONAL (2017)
Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells
Xiaohong Xu et al.
STEM CELL REPORTS (2017)
Mutant Huntingtin and Elusive Defects in Oxidative Metabolism and Mitochondrial Calcium Handling
Nickolay Brustovetsky
MOLECULAR NEUROBIOLOGY (2016)
Mitochondrial targeting of XJB-5-131 attenuates or improves pathophysiology in HdhQ150 animals with well-developed disease phenotypes
Aris Polyzos et al.
HUMAN MOLECULAR GENETICS (2016)
Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease
Xiangling Yin et al.
HUMAN MOLECULAR GENETICS (2016)
Time-Course Analysis of Protein and Lipid Oxidation in the Brains of Yac128 Huntington's Disease Transgenic Mice
Patricia S. Brocardo et al.
REJUVENATION RESEARCH (2016)
Determining Maximum Glycolytic Capacity Using Extracellular Flux Measurements
Shona A. Mookerjee et al.
PLOS ONE (2016)
Development and function of human cerebral cortex neural networks from pluripotent stem cells in vitro
Peter Kirwan et al.
DEVELOPMENT (2015)
Lack of Oxidative Stress in a Mouse Neural Stem Cell Model of Huntington's Disease
Irina V Perevoshchikova' et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Oxidative metabolism in YAC128 mouse model of Huntington's disease
James Hamilton et al.
HUMAN MOLECULAR GENETICS (2015)
Ca2+ handling in isolated brain mitochondria and cultured neurons derived from the YAC128 mouse model of Huntington's disease
Jessica J. Pellman et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Human iPSC-Based Modeling of Late-Onset Disease via Progerin-Induced Aging
Justine D. Miller et al.
CELL STEM CELL (2013)
Early Deficits in Glycolysis Are Specific to Striatal Neurons from a Rat Model of Huntington Disease
Caroline Gouarne et al.
PLOS ONE (2013)
Characterization of forebrain neurons derived from late-onset Huntington's disease human embryonic stem cell lines
Jonathan C. Niclis et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient
Jung-Il Chae et al.
BIOCHEMICAL JOURNAL (2012)
Induced Pluripotent Stem Cells from Patients with Huntington's Disease Show CAG-Repeat-Expansion-Associated Phenotypes
CELL STEM CELL (2012)
Genetic Correction of Huntington's Disease Phenotypes in Induced Pluripotent Stem Cells
Mahru C. An et al.
CELL STEM CELL (2012)
Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease
Ulziibat P. Shirendeb et al.
HUMAN MOLECULAR GENETICS (2012)
The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity
Stefano Camnasio et al.
NEUROBIOLOGY OF DISEASE (2012)
Targeting of XJB-5-131 to Mitochondria Suppresses Oxidative DNA Damage and Motor Decline in a Mouse Model of Huntington's Disease
Zhiyin Xun et al.
CELL REPORTS (2012)
Cytometric Assessment of Mitochondria Using Fluorescent Probes
Cecile Cottet-Rousselle et al.
CYTOMETRY PART A (2011)
Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage
Ulziibat Shirendeb et al.
HUMAN MOLECULAR GENETICS (2011)
Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity
Wenjun Song et al.
NATURE MEDICINE (2011)
Mitochondria in Huntington's disease
Maria Damiano et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli
Veronica Costa et al.
EMBO MOLECULAR MEDICINE (2010)
Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease
Jinho Kim et al.
HUMAN MOLECULAR GENETICS (2010)
Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
Chiara Zuccato et al.
PHYSIOLOGICAL REVIEWS (2010)
Mitochondrial structural and functional dynamics in Huntington's disease
P. Hemachandra Reddy et al.
BRAIN RESEARCH REVIEWS (2009)
Mitochondria and Huntington's Disease Pathogenesis Insight from Genetic and Chemical Models
Susan E. Browne
MITOCHONDRIA AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISORDERS (2008)
Disease-specific induced pluripotent stem cells
In-Hyun Park et al.
CELL (2008)
N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking
Adam L. Orr et al.
JOURNAL OF NEUROSCIENCE (2008)
Mutant huntingtin and mitochondrial dysfunction
Ella Bossy-Wetzel et al.
TRENDS IN NEUROSCIENCES (2008)
Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases
E. Trushina et al.
NEUROSCIENCE (2007)
Mitochondrial dysfunction in Huntington's disease:: the bioenergetics of isolated and in situ mitochondria from transgenic mice
Jorge M. A. Oliveira et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons
DTW Chang et al.
NEUROBIOLOGY OF DISEASE (2006)
Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro
E Trushina et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease
EJ Slow et al.
HUMAN MOLECULAR GENETICS (2003)
No evidence for increased oxidative damage to lipids, proteins, or DNA in Huntington's disease
ZI Alam et al.
JOURNAL OF NEUROCHEMISTRY (2000)